Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)

Dysbiosis Clinical Trial

— ICMc  

Official title:

Prospective Descriptive Study of the Cutaneous Microbiota of ICU Patients With Central Venous Catheter (ICMc)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06095076
• Other study ID #: 2023_006
• Status: Recruiting
• Start date: June 2, 2023
• Est. completion date: June 2, 2024

Study information

• Verified date: May 2023
• Source: Centre Hospitalier de Cayenne
• Contact: Ariane ROUJANSKY
• Phone: +594594395354
• Email: ariane.roujansky[@]ch-cayenne.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Intensive Care Unit (ICU) patients are exposed to catheter-related infections with an important morbidity. Catheter colonization is constant but infection is not. Cutaneous dysbiosis could be the missing link. Our study aims to evaluate the evolution of cutaneous microbiota in ICU patients with a central venous catheter in place, through metagenomics. Our main objective is to evaluate the evolution of alpha-diversity, quantified by intra-patient variation of Shannon diversity index (a diversity index used in bacterial metagenomics).

Description:

Central venous catheters (CVCs) are necessary in up to 60% of ICU patients, representing a risk of catheter-related infections with high morbidity and mortality. Catheter colonization originating mostly from the skin is constant, but infection is not. Dysbiosis is known to be associated with pathological states and infection, for example post-antibiotic C. difficile diarrheas, or atopic dermatitis, in which flares are associated with dysbiosis and S. aureus predominance. Cutanous dysbiosis could be the missing link between catheter colonization and infection. Our hypothesis is that under the influence of multiple ICU factors (stress, antibiotic administration, local dysinfection procedures), cutaneous dybiosis appears in ICU patients with a central venous catheter. All adult ICU patients with an indication for CVC placement will be included over a 6 months period. Skin swabbing will be performed on CVC insertion site before CVC placement (baseline), and then every 3 days (or when dressing is changed) while CVC is in place, then at ICU discharge. Bacterial metagenomics using bacterial DNA extraction, 16S PCR amplification and Nanopore sequencing will allow for description of cutaneous microbiota and diversity evaluation through Shannon index. Evolution of alpha-diversity will be evaluated through time-series data analysis: comparison of Shannon index at various time points with baseline Shanonn index (before CVC placement). Standard microbiologic culture of skin swabbing will be performed. General patient characteristics and informations relative to CVC infection and treatment will be collected. This study will have no impact on patient management. Category 3 Non-Interventional Human Person Research (RIPH 3)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: June 2, 2024
• Est. primary completion date: December 2, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult hospitalized in ICU at the Cayenne Hospital Center in whom the installation of a CVC is indicated

Exclusion Criteria:

• Patient under 18 years of age
• Patient or trusted person or family or relative objecting to participation in the study (refusal)
• Patient under judicial safeguard or under any other protective regime (guardianship or curatorship)
• Patient with cutaneous lesions (infection, burn) near the cutaneous insertion site of the CVC

Related Conditions & MeSH terms

• Catheter-Related Infections
• Dysbiosis
• Infections

Intervention

Diagnostic Test:
• Skin swabbing
Skin swabbing will be performed on CVC insertion site before CVC placement (baseline), and then every 3 days (or when dressing is changed) while CVC is in place, then at ICU discharge. Bacterial metagenomics using bacterial DNA extraction, 16S PCR amplification and Nanopore sequencing will allow for description of cutaneous microbiota and diversity evaluation through Shannon index. Evolution of alpha-diversity will be evaluated through time-series data analysis: comparison of Shannon index at various time points with baseline Shanonn index (before CVC placement). Standard microbiologic culture of skin swabbing will be performed.

Other:
• Data collection
General patient characteristics and informations relative to CVC infection and treatment will be collected.

Locations

Country	Name	City	State
French Guiana	Centre Hospitalier de Cayenne	Cayenne	Guyane Française

Sponsors (2)

Lead Sponsor	Collaborator
Centre Hospitalier de Cayenne	Tropical Biome and ImmunoPhysiopathology (TBIP) - French Guiana University (Université de Guyane)

Country where clinical trial is conducted

French Guiana, 

References & Publications (29)

Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, Patel S, Cutting M, Madden T, Hamilton H, Harris E, Gevers D, Simone G, McInnes P, Versalovic J. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J. 2013 Mar;27(3):1012-22. doi: 10.1096/fj.12-220806. Epub 2012 Nov 19. — View Citation

Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018 Mar;16(3):143-155. doi: 10.1038/nrmicro.2017.157. Epub 2018 Jan 15. — View Citation

Chen CH, Tu CC, Kuo HY, Zeng RF, Yu CS, Lu HH, Liou ML. Dynamic change of surface microbiota with different environmental cleaning methods between two wards in a hospital. Appl Microbiol Biotechnol. 2017 Jan;101(2):771-781. doi: 10.1007/s00253-016-7846-4. Epub 2016 Oct 22. — View Citation

Chen HS, Wang FD, Lin M, Lin YC, Huang LJ, Liu CY. Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect. 2006 Jun;39(3):231-6. — View Citation

Chien AL, Tsai J, Leung S, Mongodin EF, Nelson AM, Kang S, Garza LA. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics. JAMA Dermatol. 2019 Apr 1;155(4):425-434. doi: 10.1001/jamadermatol.2018.5221. — View Citation

Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982 Jul;37(1):318-26. doi: 10.1128/iai.37.1.318-326.1982. — View Citation

Coates M, Lee MJ, Norton D, MacLeod AS. The Skin and Intestinal Microbiota and Their Specific Innate Immune Systems. Front Immunol. 2019 Dec 17;10:2950. doi: 10.3389/fimmu.2019.02950. eCollection 2019. — View Citation

Cusco A, Catozzi C, Vines J, Sanchez A, Francino O. Microbiota profiling with long amplicons using Nanopore sequencing: full-length 16S rRNA gene and the 16S-ITS-23S of the rrn operon. F1000Res. 2018 Nov 6;7:1755. doi: 10.12688/f1000research.16817.2. eCollection 2018. — View Citation

Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001 Nov 1;33(9):1567-72. doi: 10.1086/323130. Epub 2001 Sep 26. — View Citation

Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC; NISC Comparative Sequencing Program; Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. Topographical and temporal diversity of the human skin microbiome. Science. 2009 May 29;324(5931):1190-2. doi: 10.1126/science.1171700. — View Citation

Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 Apr;9(4):244-53. doi: 10.1038/nrmicro2537. Erratum In: Nat Rev Microbiol. 2011 Aug;9(8):626. — View Citation

Haegeman B, Hamelin J, Moriarty J, Neal P, Dushoff J, Weitz JS. Robust estimation of microbial diversity in theory and in practice. ISME J. 2013 Jun;7(6):1092-101. doi: 10.1038/ismej.2013.10. Epub 2013 Feb 14. — View Citation

Hooks KB, O'Malley MA. Dysbiosis and Its Discontents. mBio. 2017 Oct 10;8(5):e01492-17. doi: 10.1128/mBio.01492-17. — View Citation

Kim BR, Shin J, Guevarra R, Lee JH, Kim DW, Seol KH, Lee JH, Kim HB, Isaacson R. Deciphering Diversity Indices for a Better Understanding of Microbial Communities. J Microbiol Biotechnol. 2017 Dec 28;27(12):2089-2093. doi: 10.4014/jmb.1709.09027. — View Citation

Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarow HD; NISC Comparative Sequence Program; Murray PR, Turner ML, Segre JA. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012 May;22(5):850-9. doi: 10.1101/gr.131029.111. Epub 2012 Feb 6. — View Citation

Matsuo Y, Komiya S, Yasumizu Y, Yasuoka Y, Mizushima K, Takagi T, Kryukov K, Fukuda A, Morimoto Y, Naito Y, Okada H, Bono H, Nakagawa S, Hirota K. Full-length 16S rRNA gene amplicon analysis of human gut microbiota using MinION nanopore sequencing confers species-level resolution. BMC Microbiol. 2021 Jan 26;21(1):35. doi: 10.1186/s12866-021-02094-5. — View Citation

McBride ME, Duncan WC, Knox JM. The environment and the microbial ecology of human skin. Appl Environ Microbiol. 1977 Mar;33(3):603-8. doi: 10.1128/aem.33.3.603-608.1977. — View Citation

Meylan P, Lang C, Mermoud S, Johannsen A, Norrenberg S, Hohl D, Vial Y, Prod'hom G, Greub G, Kypriotou M, Christen-Zaech S. Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy. J Invest Dermatol. 2017 Dec;137(12):2497-2504. doi: 10.1016/j.jid.2017.07.834. Epub 2017 Aug 24. — View Citation

Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, Shafiq F, Kotol PF, Bouslimani A, Melnik AV, Latif H, Kim JN, Lockhart A, Artis K, David G, Taylor P, Streib J, Dorrestein PC, Grier A, Gill SR, Zengler K, Hata TR, Leung DY, Gallo RL. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017 Feb 22;9(378):eaah4680. doi: 10.1126/scitranslmed.aah4680. — View Citation

NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2016 Jan 4;44(D1):D7-19. doi: 10.1093/nar/gkv1290. Epub 2015 Nov 28. — View Citation

Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993 Aug;168(2):400-7. doi: 10.1093/infdis/168.2.400. — View Citation

Rozas M, Brillet F, Callewaert C, Paetzold B. MinION Nanopore Sequencing of Skin Microbiome 16S and 16S-23S rRNA Gene Amplicons. Front Cell Infect Microbiol. 2022 Jan 5;11:806476. doi: 10.3389/fcimb.2021.806476. eCollection 2021. — View Citation

Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004 Jan;30(1):62-7. doi: 10.1007/s00134-003-2045-z. Epub 2003 Nov 26. — View Citation

Seekatz AM, Young VB. Clostridium difficile and the microbiota. J Clin Invest. 2014 Oct;124(10):4182-9. doi: 10.1172/JCI72336. Epub 2014 Jul 18. — View Citation

Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. eCollection 2016 Aug. — View Citation

Sommer F, Anderson JM, Bharti R, Raes J, Rosenstiel P. The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol. 2017 Oct;15(10):630-638. doi: 10.1038/nrmicro.2017.58. Epub 2017 Jun 19. — View Citation

Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol. 1999 Jun;20(6):396-401. doi: 10.1086/501639. — View Citation

Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. J Hosp Infect. 2009 Jun;72(2):97-103. doi: 10.1016/j.jhin.2008.12.012. Epub 2009 Feb 25. — View Citation

Timsit JF. [Updating of the 12th consensus conference of the Societe de Reanimation de langue francaise (SRLF): catheter related infections in the intensive care unit]. Ann Fr Anesth Reanim. 2005 Mar;24(3):315-22. doi: 10.1016/j.annfar.2004.12.022. French. — View Citation

* Note: There are 29 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evolution of alpha-diversity	Comparison of Shannon index at various time points with baseline Shannon index (before Central Venous Catheter placement through leaving intensive care service). The higher the Shannon index, the greater the diversity.	Baseline
Primary	Evolution of alpha-diversity	Comparison of Shannon index at various time points with baseline Shannon index (before Central Venous Catheter placement through leaving intensive care service). The higher the Shannon index, the greater the diversity.	Day 3
Secondary	Skin swabs Metagenomics	Metagenomics: Alpha and beta-diversity of skin swabs	Baseline
Secondary	Skin colonization	Skin colonization: positive standard culture of skin swabs	Baseline
Secondary	Catheter-related colonization	Catheter-related colonization: standard central line culture positivity	Baseline
Secondary	Central Venous Catheter's Metagenomics	Metagenomics: alpha and beta-diversity of Central Venous Catheter at removal	Baseline
Secondary	Catheter related Infection	Clinical signs and blood culture and/or positive catheter culture	Baseline
Secondary	Skin swabs Metagenomics	Comparison of Shannon index at various time points with baseline Shannon index (before Central Venous Catheter placement through leaving intensive care service). The higher the Shannon index, the greater the diversity.	Day 3
Secondary	Skin colonization	Skin colonization: positive standard culture of skin swabs	Day 3
Secondary	Catheter-related colonization	Catheter-related colonization: standard central line culture positivity	Day 3
Secondary	Central Venous Catheter's Metagenomics	Metagenomics: alpha and beta-diversity of Central Venous Catheter at removal	Day 3
Secondary	Catheter related Infection	Clinical signs and blood culture and/or positive catheter culture	Day 3

External Links

•   Santé Publique France- Mission Nationale SPIADI. Surveillance des infections associées aux dispositifs invasifs. Mission nationale SPIADI. Résultats de la surveillance menée en 2019.